Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 : Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis on Adult Face

NCT02004860 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT02004860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02004860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 : Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis on Adult Face
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2014
Completion date
October 31, 2017
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe seborrheic dermatitis